Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Schwab

Showing results (11-20 of 672) with videos related to

Pageof 68
Sort By:
Lancet (London, England)|October 30, 2012
Antiarrhythmic drug treatment after cardioversion of atrial fibrillationMatthias Schwab, Klaus Moerike
Expert Review of Clinical Pharmacology|November 25, 2011
Organic cation transporter pharmacogenomics and drug-drug interactionAnne T Nies, Matthias Schwab
Pharmacology & Therapeutics|January 22, 2013
Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variationUlrich M Zanger, Matthias Schwab
Neuroscience and Biobehavioral Reviews|June 21, 2020
Prenatal stress and brain disorders in later lifeMatthias Schwab, Otto W Witte
The New England Journal of Medicine|February 4, 2011
CYP2C19 genotype and outcomes of clopidogrel treatmentTobias Geisler, Boris Bigalke, Matthias Schwab
Clinical Pharmacokinetics|July 28, 2007
Clinical pharmacokinetics and use of infliximabUlrich Klotz, Alexander Teml, Matthias Schwab
Clinical and Translational Science|April 17, 2018
Clinical and Functional Relevance of the Monocarboxylate Transporter Family in Disease Pathophysiology and Drug TherapyPascale Fisel, Elke Schaeffeler, Matthias Schwab
Basic & Clinical Pharmacology & Toxicology|July 13, 2004
CYP2C19 polymorphism and proton pump inhibitorsUlrich Klotz, Matthias Schwab, Gerhard Treiber
Journal of Gastroenterology and Hepatology|August 18, 2005
Determinants of non-response in Helicobacter pylori eradication trialsUlrich Klotz, Gerhard Treiber, Matthias Schwab
European Journal of Preventive Cardiology|March 30, 2018
Reply to the letter 'Is a rapid increase in nitrogen oxides really associated with an acute myocardial infarction?'Florian Rakers, Marius Rasche, Matthias Schwab
Pageof 68

Showing results (11-20 of 672) with videos related to

Sort By:
Pageof 68
Lancet (London, England)|October 30, 2012
Antiarrhythmic drug treatment after cardioversion of atrial fibrillationMatthias Schwab, Klaus Moerike
Expert Review of Clinical Pharmacology|November 25, 2011
Organic cation transporter pharmacogenomics and drug-drug interactionAnne T Nies, Matthias Schwab
Pharmacology & Therapeutics|January 22, 2013
Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variationUlrich M Zanger, Matthias Schwab
Neuroscience and Biobehavioral Reviews|June 21, 2020
Prenatal stress and brain disorders in later lifeMatthias Schwab, Otto W Witte
The New England Journal of Medicine|February 4, 2011
CYP2C19 genotype and outcomes of clopidogrel treatmentTobias Geisler, Boris Bigalke, Matthias Schwab
Clinical Pharmacokinetics|July 28, 2007
Clinical pharmacokinetics and use of infliximabUlrich Klotz, Alexander Teml, Matthias Schwab
Clinical and Translational Science|April 17, 2018
Clinical and Functional Relevance of the Monocarboxylate Transporter Family in Disease Pathophysiology and Drug TherapyPascale Fisel, Elke Schaeffeler, Matthias Schwab
Basic & Clinical Pharmacology & Toxicology|July 13, 2004
CYP2C19 polymorphism and proton pump inhibitorsUlrich Klotz, Matthias Schwab, Gerhard Treiber
Journal of Gastroenterology and Hepatology|August 18, 2005
Determinants of non-response in Helicobacter pylori eradication trialsUlrich Klotz, Gerhard Treiber, Matthias Schwab
European Journal of Preventive Cardiology|March 30, 2018
Reply to the letter 'Is a rapid increase in nitrogen oxides really associated with an acute myocardial infarction?'Florian Rakers, Marius Rasche, Matthias Schwab
Pageof 68